Global Lung Cancer Market

GLOBAL Lung Cancer Surgery Market
Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach
USD 30.32 billion by 2021 with a CAGR of 6.92 %.
Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are
many ways to treat Lung Cancer. Some of them are Chemotherapy, Radiotherapy, Laser
therapy, and Surgery. Surgery involves removal of infected section from lungs. There are
many types of Lung Cancer Surgery like Lobectomy, Pneumonectomy, Sleeve Resection and
Segmentectomy.
Lung Cancer is kind of cancer which starts in Lung tissue or its surrounding parts. There are
various types of treatments available to treat cancer like Chemotherapy, Radiotherapy,
Laser Therapy and Surgery. Surgery involves removal of infected part from the lungs.
In some cases, surgery will be used with other treatment methods to cure cancer. Surgery is
only used if cancer cells don’t spread very near to the heart.
Rising pollution levels, increasing number of cigarette smokers, rising incidence and
prevalence of Lung Cancer and rising geriatric population are some of the major factors
driving the market. However, high cost of Lung Cancer surgery is restraining the growth of
the market.
Lung Cancer Surgery Market is segmented based on Procedure and Device. Based on
Procedure, market is segmented into Thoracotomy and Minimally Invasive. Based on
Thoracotomy, market is further segmented into Lobectomy, Pneumonectomy, Sleeve
Resection, and Segmentectomy. Based on Device, market is segmented into Surgical,
Monitoring and Visualizing Systems. Based on Surgical Devices, market is further segmented
into Clamps, Forceps, Retractors, Staplers, Cutters, Scissors, Elevators, RIB Sheers, Trocars.
Based on Monitoring Devices, market is further segmented into Cameras & Video Support.
Based on Visualizing Devices, market is further segmented into Endoscopic Trocars with
optical views, Endo surgical Equipment. Surgical Instruments segment is expected to
dominate the market owing to the shorter lifespan of devices and wider adoption of these
devices. Minimally Invasive surgeries are expected to grow at highest CAGR owing to the
rising awareness among people for early detection of lung cancer and advantages of
Minimally Invasive Surgeries over conventional surgeries.
Geographically, market is further segmented into Asia-Pacific, Europe, Latin America, North
America and Middle East and Africa. North America accounted for largest share in the
market owing to rising geriatric population, increasing reimbursements for surgeries, and
technological advancement in this field.
Key players in the market include Ethicon US LLC, Intuitive Surgical Inc., Olympus
Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann
Instrumente GmbH, Scanlan International Inc., and Trokamed GmbH.
TABLE OF CONTENT
1.Introduction
1.1 Market Definition
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com